Rutten K, Prickaerts J, Schaenzle G, Rosenbrock H, Blokland A
Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Universiteitssingel 50, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
Neurobiol Learn Mem. 2008 Oct;90(3):569-75. doi: 10.1016/j.nlm.2008.04.016. Epub 2008 Jun 16.
In the present study the effects of sub-chronic rolipram treatment in an object recognition task in 3-month-old male rats were investigated. Rats remember which object they have explored in a previous trial (T1) when they are tested 1 h later (T2). However, when tested 24 h later, they do not remember which object was presented to them in the first trial. Drug treatments may improve discrimination performance after 24 h, i.e., improve memory for the familiar object. Rats were sub-chronically treated with 0.5 mg/kg rolipram (p.o.) for five consecutive days and tested with a 24 h delay between T1 and T2. Memory performance in the object recognition task was assessed before, during and after sub-chronic treatment. In addition, we investigated whether the timing of the final dose, i.e., 24, 1, or 6 h before training, had an effect on memory performance. During sub-chronic treatment, i.e., after 2-3 days of rolipram treatment, moderate effects on memory performance were observed. Regardless of when the final administration was given, sub-chronic rolipram treatment improved long-term memory performance. Since plasma and brain rolipram levels were undetectable at 24 h before the test, and acute treatment with rolipram 24 h before training had no effects, the observed memory enhancement cannot be attributed to acute rolipram effects. The long-term memory enhancing effects of rolipram might be explained by long-lasting neuronal changes by the chronic treatment due to recurring activation of the cAMP/PKA/CREB pathway leading to CREB phosphorylation.
在本研究中,我们调查了亚慢性咯利普兰治疗对3月龄雄性大鼠物体识别任务的影响。大鼠在1小时后接受测试(T2)时,能够记住它们在之前的试验(T1)中探索过的物体。然而,当在24小时后进行测试时,它们不记得第一次试验中呈现给它们的是哪个物体。药物治疗可能会在24小时后改善辨别能力,即提高对熟悉物体的记忆。大鼠连续5天接受0.5mg/kg咯利普兰(口服)亚慢性治疗,并在T1和T2之间延迟24小时进行测试。在亚慢性治疗之前、期间和之后评估物体识别任务中的记忆表现。此外,我们研究了最后一剂药物的给药时间,即在训练前24小时、1小时或6小时,是否对记忆表现有影响。在亚慢性治疗期间,即咯利普兰治疗2-3天后,观察到对记忆表现有中度影响。无论最后一次给药时间如何,亚慢性咯利普兰治疗均改善了长期记忆表现。由于在测试前24小时未检测到血浆和脑内咯利普兰水平,且在训练前24小时给予咯利普兰急性治疗没有效果,因此观察到的记忆增强不能归因于咯利普兰的急性作用。咯利普兰的长期记忆增强作用可能是由于慢性治疗通过cAMP/PKA/CREB途径的反复激活导致CREB磷酸化,从而引起持久的神经元变化来解释的。